Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β 2025-07-01
  2. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 2024-08-22
  3. APOEε4 potentiates amyloid β effects on longitudinal tau pathology 2023-09-25

Studies

8 studies carry this tag.

Date range

2012 to 2025

Top journals

  • Neurobiology of aging 2
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Brain : a journal of neurology 1
  • CPT: pharmacometrics & systems pharmacology 1
  • Frontiers in aging neuroscience 1

7 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-β

    ✓ Peer-reviewed alzhub usefulness score 72 out of 100. Brain : a journal of neurology 2025-07-01 Biomarkers

    Although APOE4 is strongly associated with amyloid-β (Aβ), its relationship with tau accumulation is less understood.

  2. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neurobiology of aging 2024-08-22 Biomarkers

    One-hundred-thirthy-three participants, namely 55 A+T+N+ AD, 28 Neurodegenerative disorders (NDD) and 50 controls were enrolled for the study.

  3. APOEε4 potentiates amyloid β effects on longitudinal tau pathology

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Nature aging 2023-09-25 Biomarkers

    The mechanisms by which the apolipoprotein E ε4 (APOEε4) allele influences the pathophysiological progression of Alzheimer's disease (AD) are poorly understood.

  4. Population pharmacokinetic-pharmacodynamic analyses of amyloid positron emission tomography and plasma biomarkers for lecanemab in subjects with early Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. CPT: pharmacometrics & systems pharmacology 2022-09-27 Biomarkers

    Lecanemab is a humanized immunoglobulin G1 monoclonal antibody that selectively binds to soluble Aβ aggregate species, while demonstrating low affinity for Aβ monomer.

  5. Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2017-07-12 Biomarkers

    Assay drift may reduce statistical power or even confound analyses.

  6. Amyloid Beta1-42 and the Phoshorylated Tau Threonine 231 in Brains of Aged Cynomolgus Monkeys (Macaca fascicularis)

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Frontiers in aging neuroscience 2014-11-10 Biomarkers

    Pathological hallmarks indicative of Alzheimer's disease (AD), which are the plaques of amyloid beta1-42 and neurofibrillary tangles, were found in brain of aged cynomolgus monkey.

  7. Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of aging 2014-05-27 Biomarkers

    Cellular studies suggest sphingolipids may cause or accelerate amyloid-beta (Aβ) and tau pathology but in vivo human studies are lacking.

  8. Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2012-01-01 Biomarkers

    Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly correlated with the accumulation of amyloid-β (Aβ) peptides (mainly Aβ(1-42)).

All topic tags with their study counts